Daniël M. Jonker

Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies

Radojka M. Savić, Daniël M. Jonker, Thomas Kerbusch et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2007 · 487 citations

Pharmacokinetic Studies, Pharmacokinetic Modeling, Pharmacological Study +8

Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers

P. D. Knoester, Daniël M. Jonker, Ruud T. M. van der Hoeven et al. · British Journal of Clinical Pharmacology · 2002 · 154 citations · Full text

A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data

Daniël M. Jonker, Leslie A. Kenna, DJ Leishman et al. · Clinical Pharmacology & Therapeutics · 2005 · 81 citations

Population Pharmacokinetics of Liraglutide, a Once‐Daily Human Glucagon‐Like Peptide‐1 Analog, in Healthy Volunteers and Subjects With Type 2 Diabetes, and Comparison to Twice‐Daily Exenatide

Estelle Watson, Daniël M. Jonker, Lisbeth V. Jacobsen et al. · The Journal of Clinical Pharmacology · 2010 · 51 citations

Diabetes Management, Pharmacokinetic Modeling, Diabetes +11

Dosing Rationale for Liraglutide in Type 2 Diabetes Mellitus: A Pharmacometric Assessment

Steen H. Ingwersen, Manoj Khurana, Rajanikanth Madabushi et al. · The Journal of Clinical Pharmacology · 2011 · 34 citations

Obesity, Metabolic Syndrome, Nutrition +12